SYNERGY TECHNOLOGY LTD

Company number 03459600 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: Synergy Technology Ltd

1. Financial Health Score: B-

Explanation: The patient exhibits signs of robust long-term vitality with consistent net asset growth over a decade, but is showing acute symptoms of balance sheet strain in 2024. The significant swelling of liabilities — particularly trade creditors and other creditors — has outpaced asset growth, creating liquidity pressure. The business is fundamentally sound but carrying concerning levels of short-term obligations that require careful management.


2. Key Vital Signs

Balance Sheet Strength: Moderate but Weakening

Metric 2024 2023 Change Assessment
Net Assets £388,118 £362,775 +7.0% ✅ Positive growth
Net Current Assets £300,294 £311,114 -3.5% ⚠️ Declining
Cash £795,562 £585,550 +35.9% ✅ Strong recovery
Total Liabilities £1,444,842 £946,646 +52.6% 🔴 Significant increase

Interpretation: The company's "bone density" (net assets) continues to strengthen year-on-year, but the "blood pressure" (liabilities relative to assets) has spiked dangerously. A 52.6% increase in liabilities in a single year is a symptom that warrants immediate investigation.

Liquidity Ratios

Ratio 2024 2023 Healthy Benchmark
Current Ratio 1.21 1.33 1.50+
Quick Ratio 1.21 1.33 1.00+
Cash to Current Liabilities 0.55 0.62 0.50+

Interpretation: The current ratio has dipped below the healthy threshold of 1.5, meaning the company has limited headroom to meet its short-term obligations. Think of it as the business having a slightly restricted airway — it can breathe, but not as freely as it should. The cash ratio at 0.55 means the company can cover approximately 55% of current liabilities from cash alone, which provides a reasonable safety net but not a comfortable one.

Leverage

Metric 2024 2023
Debt-to-Equity Ratio 3.72 2.61
Net Assets to Total Assets 21.2% 26.6%

Interpretation: The debt-to-equity ratio has deteriorated significantly from 2.61 to 3.72. For every £1 of shareholder equity, the company now carries £3.72 in liabilities. This is the financial equivalent of carrying too much weight — the business is heavily leveraged on its obligations, though much of this appears to be operational creditors rather than bank debt.


3. Diagnosis

Primary Condition: Chronic Equity Deficiency with Acute Liability Inflation

The balance sheet reveals a business that has grown its asset base substantially — from £470,544 in 2015 to £1,832,960 in 2024, nearly a fourfold increase. This is impressive top-line expansion. However, this growth has been financed increasingly through liabilities rather than retained profits, creating an imbalance.

Healthy Trends (The Good News):

  1. Consistent Net Asset Growth: Ten consecutive years of increasing shareholders' funds, from £88,787 (2015) to £388,118 (2024). This demonstrates the business has been profitable and retaining earnings over the long term.

  2. Strong Cash Position: £795,562 in cash represents 43.4% of total assets. The business maintains healthy cash reserves, providing a buffer against operational shocks.

  3. Stable Employee Base: 26 employees in 2024 (up from 25 in 2023) suggests steady, manageable growth rather than aggressive hiring.

  4. Filing Compliance: All statutory filings are current, with no overdue accounts or confirmation statements. This indicates good corporate governance hygiene.

Symptoms of Concern (The Worrying Signs):

  1. Trade Creditors Surge: Trade creditors exploded from £95,051 (2023) to £322,686 (2024) — a 239% increase. This could indicate: - The business is deliberately stretching supplier payment terms to preserve cash - A significant increase in purchasing activity that hasn't yet converted to revenue - Potential cash flow management difficulties

  2. Other Creditors: At £899,705, "other creditors" represents 62% of current liabilities and 49% of total assets. This is an unusually large figure that lacks transparency in the filed accounts. It could include accruals, deferred income, director loans, or other obligations. Without understanding this composition, it represents a significant diagnostic uncertainty.

  3. Debtors Expansion: Trade debtors grew 41% from £526,696 to £703,585. While this may reflect revenue growth, it could also indicate slower collection or extended credit terms to customers. The debtors collection period needs investigation.

  4. Management Fees to Controlling Entities: £193,000 paid in management fees to entities with control represents a significant extraction of value from the business. This is 5.5% of net assets and represents a recurring cash outflow that benefits the parent rather than strengthening the subsidiary's balance sheet.

  5. Slowing Net Asset Growth: While still positive, the rate of net asset growth has decelerated: - 2024: 7.0% - 2023: 9.4% - 2022: 9.3% - 2021: 8.5% - 2020: 4.9%

Balance Sheet Composition Analysis (2024)

Component Amount % of Total Assets
Fixed Assets £87,824 4.8%
Trade Debtors £703,585 38.4%
Group Debtors £57,045 3.1%
Other Debtors £188,944 10.3%
Cash £795,562 43.4%

The business is asset-light (only 4.8% in fixed assets) and heavily reliant on debtors and cash. This is typical for an IT consultancy but means the business is vulnerable to debtor collection issues.

Long-Term Trajectory: Positive Despite Recent Strain

Year Net Assets YoY Growth
2015 £88,787 —
2016 £145,775 +64.2%
2017 £207,811 +42.6%
2018 £244,082 +17.5%
2019 £266,623* +9.2%
2020 £279,567 +4.9%
2021 £303,462 +8.5%
2022 £331,602 +9.3%
2023 £362,775 +9.4%
2024 £388,118 +7.0%

*Note: 2019 shows a discrepancy between net assets (£266,623) and shareholders' funds (£264,623), suggesting a minor accounting adjustment.

The long-term trend is undeniably positive — the business has grown its equity base over fourfold in a decade. However, the 2024 growth rate of 7.0% is the second-lowest in this period (after 2020's pandemic-affected 4.9%).


4. Recommendations

Immediate Actions (Critical Care)

  1. Investigate the "Other Creditors" Balance: At £899,705, this represents nearly half of total assets. Request a detailed breakdown from management. Understanding whether this comprises accrued costs, deferred revenue, director loans, or other obligations is essential for accurate diagnosis.

  2. Review Trade Creditors Position: The 239% increase demands explanation. If this represents deliberate payment stretching, it risks damaging supplier relationships and potentially losing early payment discounts. If it reflects genuine business growth, ensure the revenue conversion is on track.

  3. Accelerate Debtor Collection: With £703,585 in trade debtors, even a 10-day improvement in collection could release approximately £19,000-£25,000 in cash flow (assuming £2.5-3M annual revenue based on the scale of operations).

Medium-Term Actions (Rehabilitation)

  1. Strengthen Working Capital: The declining net current assets (from £311,114 to £300,294) and current ratio (from 1.33 to 1.21) suggest the business is operating with increasingly thin liquid margins. Target a current ratio of 1.5 by either: - Reducing current liabilities through structured repayment - Building current assets through retained profits rather than increasing debtors

  2. Review Management Fee Arrangement: The £193,000 annual management fee paid to controlling entities should be benchmarked against market rates. If this represents genuine services, it should be documented accordingly. If it's a mechanism for profit extraction, consider whether dividend payments might be more transparent and tax-efficient.

  3. Improve Balance Sheet Transparency: The company files under the "small companies regime" which limits disclosure. While legally compliant, greater transparency in the breakdown of creditors and debtors would improve stakeholder confidence and could support better credit terms from suppliers and financiers.

Long-Term Actions (Preventative Care)

  1. Develop a Formal Cash Flow Forecasting Process: Given the business's reliance on debtors (38.4% of assets) and the seasonal nature of IT consultancy payments, implement rolling 13-week cash flow forecasts to anticipate and prevent liquidity crunches.

  2. Consider Capital Restructuring: With a debt-to-equity ratio of 3.72, the business is highly leveraged by operational creditors. Explore opportunities to: - Convert some short-term obligations to longer-term arrangements - Negotiate extended payment terms with key suppliers - Consider whether director loans (if included in other creditors) could be restructured or converted to equity

  3. Monitor Related Party Balances: Amounts owed by group undertakings (£57,045) and amounts owed to group undertakings (£14,483) should be regularly reconciled and managed to ensure the subsidiary's cash flow isn't disadvantaged by group treasury arrangements.


Prognosis

Short-term (6-12 months): Cautiously stable. The business has sufficient cash reserves (£795,562) to meet immediate obligations, but the inflated creditor position requires active management. If trade creditors are being stretched, suppliers may begin demanding stricter terms, which could create a cash flow cascade effect.

Medium-term (1-3 years): Positive, assuming the business addresses its balance sheet imbalances. The underlying business model — IT consultancy focused on Microsoft Dynamics and related platforms — operates in a growing market. The consistent profit generation evidenced by rising P&L reserves suggests the core business is healthy. The key risk is that continued liability growth outpaces equity accumulation, eventually eroding the working capital buffer.

Long-term (3-5 years): Favorable, provided the business maintains its current growth trajectory and addresses the leverage concerns. The company has demonstrated remarkable resilience over its 27-year history and has built substantial equity. However, as a subsidiary of Pure Synergy Group Ltd (which owns 50-75%) with name shown to subscribers holding 75%+ personally, strategic decisions will be influenced by group-level considerations, which may not always align with optimizing this individual company's balance sheet.


Synergy Technology Ltd presents a mixed financial picture: a healthy long-term trajectory of consistent net asset growth from £89k to £388k over a decade, combined with acute short-term balance sheet strain evidenced by a 52.6% surge in liabilities during 2024. The current ratio has fallen below the healthy threshold at 1.21,

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 18 September 2026